Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5

Veterinary Immunology and Immunopathology

Volumn 116, Issue 1-2, 2007, Pages 79-84

  Fischer, Geferson ^a   Cleff, Marlete Brum ^a   Dummer, Luana Alves ^a   Paulino, Niraldo ^b   Paulino, Amarílis Scremin ^b   Vilela, Camila de Oliveira ^a   Campos, Fabrício Souza ^a   Storch, Tiago ^a   Vargas, Gilberto D'Avila ^a   Hübner, Silvia de Oliveira ^a   Vidor, Telmo ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b Universidade Bandeirante de Sao Paulo   (Brazil)

Author keywords

Antibodies; Bovines; Green propolis; Immunological adjuvant

Indexed keywords

3,5 DIPRENYL 4 HYDROXYCINNAMIC ACID; ARTEPILLIN C; CINNAMIC ACID DERIVATIVE; GREEN PROPOLIS EXTRACT; HERPES VACCINE; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; PHENOL DERIVATIVE; PROPOLIS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; COW; EVALUATION; FEMALE; HUMORAL IMMUNITY; MALE; NONHUMAN; STATISTICAL SIGNIFICANCE; VACCINE PRODUCTION; VARICELLA ZOSTER VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; ENCEPHALITIS, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 5, BOVINE; HERPESVIRUS VACCINES; IMMUNIZATION; MALE; MENINGOENCEPHALITIS; NEUTRALIZATION TESTS; PROPOLIS;

ANIMALIA; BOVINE HERPESVIRUS 5;

EID: 33847316882     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.01.003     Document Type: Article

References (34)

1. Ansorge S., Reinhold D., and Lendeckel U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-β1 production of human immune cells. Z. Naturforsch. 58c (2003) 580-589
2. Babiuk L.A., Hurk S.D.L., and Tikoo S.K. Immunology of bovine herpesvirus 1 infection. Vet. Microbiol. 53 (1996) 31-42
3. Bankova V.S., Castro S.L., and Marcucci M.C. Propolis: recent advances in chemistry and plant origin. Apidologie 31 (2000) 3-15
4. Bankova V. Recent trends and important developments in propolis research. Evid. Based Complement. Alternat. Méd. 2 (2005) 29-32
5. Barr T.A., Carlring J., and Heath A.W. Co-stimulatory agonists as immunological adjuvants. Vaccine 24 (2006) 3399-3407
6. Blom A.G., and Hilgers L.A. The sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition. Vaccine 23 (2004) 743-754
7. Cox J.C., and Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 15 (1997) 246-256
8. De Campos R.O., Paulino N., da Silva C.H., Scremin A., and Calixto J.B. Anti-hyperalgesic effect of an ethanolic extract of propolis in mice and rats. J. Pharm. Pharmacol. 50 (1998) 1187-1193
9. De Castro S.L. Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Annu. Rev. Biomed. Sci. 3 (2001) 49-83
10. Dimov V., Ivanovska N., Bankova V., and Popov S. Immunomodulatory action of propolis: IV. Prophylactic activity against Gram-negative infections and adjuvant effect of the water-soluble derivate. Vaccine 10 (1992) 817-823
11. Estrada A., Katselis G.S., Laarveld B., and Barl B. Isolation and evaluation of immunological adjuvant activities of saponins from Polygala senega L. Comp. Immunol. Microbiol. Infect. Dis. 23 (2000) 27-43
12. Fenner F.J., Gibbs E.P., Murphy F.A., Rott R., Studert M.J., and White D. Veterinary Virology (1993), Academic Press, San Diego p. 666
13. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96 (2002) 67-202
14. House J.A., and Baker J.A. Bovine herpesvirus IBR-IPV. The antibody virus neutralization reaction. Cornell Vet. 61 (1971) 320-335
15. Jansen T., Hofmans M.P.M., Theelen M.J.G., Manders F., and Schijns V.E.J.C. Structure and oil type-based efficacy of emulsion adjuvants. Vaccine 24 (2006) 5400-5405
16. Kimoto T., Arai S., Kohguchi M., Aga M., Nomura Y., Micallef M.J., Kurin M., and Mito K. Apoptosis and suppression of tumor growth by artepillin C extracted from brazilian propolis. Cancer Detect. Prev. 22 (1998) 506-515
17. Kujumgiev A., Tsvetkova I., Serkedjieva Yu., Bankova V., Christov R., and Popov S. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnoparmacol. 64 (1999) 235-240
18. Lazarowics M., Steck F., Ackermann M., and Kihm U. Prüfung von zwei Impfstoffen gegen die Infektiöse Bovine Rhinotracheitis. Schweiz. Arch. Tierheilk. 125 (1983) 797-808
19. Leclerc C. New approaches in vaccine development. Comp. Immunol. Microbiol. Infect. Dis. 26 (2003) 329-341
20. Lindblad E.B. Freund's adjuvants. In: O'Hagan D.T. (Ed). Vaccine Adjuvants (2000), Humana Press, Totowa, NJ 49-63
21. Marcucci M.C. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26 (1995) 83-99
22. Marcucci M.C., Ferreres F., García-Viguera C., Bankova V.S., De Castro S.L., Dantas A.P., Valente P.H.M., and Paulino N. Phenolic compounds from Brazilian propolis with pharmacological activities. J. Ethnopharmacol. 74 (2001) 105-112
23. Mayr A., Bachmann P.A., Bibrack B.M., and Withmann G. Virologische Arbeitsmethoden - Band IV - Sicherheit bei virologischen arbeiten - Biometrische Methoden (1982), Gustav Fischer Verlag, Stutgart p. 666
24. Miyataka H., Nishiki M., Matsumoto H., Fujimoto T., Matsuka M., Isobe A., and Satoh T. Evaluation of propolis. I: Evaluation of Brazilian and Chinese propolis by enzymatic and physico-chemical methods. Biol. Pharm. Bull. 20 (1997) 496-501
25. Orsi R.O., Funari S.R.C., Soares A.M.V.C., Calvi S.A., Oliveira S.L., Sforcin J.M., and Bankova V. Immunomodulatory action of propolis on macrophage activation. J. Venom. Anim. Toxins 6 (2000) 205-219
26. Orsolic N., Terzic S., Sver L., and Basic I. Polyphenolic compounds from propolis modulate immune responses and increase host resistence to tumor cells. Food Agric. Immunol. 16 (2005) 165-179
27. Ozkul Y., Silici S., and Eroglu E. The anticarcinogenic effect of propolis in human lymphocytes culture. Phytomedicine 12 (2005) 742-747
28. Paulino N., Scremin F.M., Raichaski L.B., Marcucci M.C., Scremin A., and Calixto J.B. Mechanisms involved in the relaxant action of the ethanolic extract of propolis in the guinea-pig trachea in-vitro. J. Pharm. Pharmacol. 54 (2002) 1-9
29. Scheller S., Owczarek S., Krol W., Malinowska B., Nikodemowicz E., and Aleksandrowicz J. Immunisierungsversuche bei zwei fallen von alveolitis fibroticans bei abnehmender leistungsfahigkeit des immunsystems unter anwendung von propolis-athanolextrakt (EEP), esberitox N und eines calcium-magnesium-praparates (dolomit.). Heikunst 102 (1989) 249-255
30. Sforcin J.M., Kanero R., and Funari S.R.C. Absence of seasonal effect on the immunomodulatory action of brazilian propolis on natural killer activity. J. Venom. Anim. Toxins 8 (2002) 19-29
31. Sforcin J.M., Orsi R.O., and Bankova V. Effect of propolis, some isolated compounds and its source plant on antibody production. J. Ethnopharmacol. 98 (2005) 301-305
32. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm. Res. 19 (2002) 715-728
33. Storni T., Kündig T.M., Senti G., and Johansen P. Immunity in response to particulate antigen-delivery systems. Adv. Drug Deliv. Rev. 57 (2005) 333-355
34. USDA. Animal and Plant Health Inspection Service (2005), USDA pp. 683-684